Detalhe da pesquisa
1.
Impact of natural menopause on multiple sclerosis: a multicentre study.
J Neurol Neurosurg Psychiatry
; 90(11): 1201-1206, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189614
2.
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.
Mult Scler
; 25(9): 1263-1272, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30044207
3.
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy.
J Neurol
; 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38844694
4.
Cladribine vs other drugs in MS: Merging randomized trial with real-life data.
Neurol Neuroimmunol Neuroinflamm
; 7(6)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801167
5.
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study.
Mult Scler Relat Disord
; 42: 102059, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208344
6.
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study.
Neurology
; 89(22): 2222-2229, 2017 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29093064
7.
Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy.
Neuropsychiatr Dis Treat
; 9: 81-5, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23355779
8.
Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine.
J Headache Pain
; 8(5): 283-8, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17955167